A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 33 (4) , 694-701
- https://doi.org/10.1016/s0272-6386(99)70221-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormoneKidney International, 1999
- Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failureAmerican Journal of Kidney Diseases, 1997
- Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjectsJournal of the American College of Cardiology, 1994
- Parathyroid gland function in chronic renal failureKidney International, 1993
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing DialysisNew England Journal of Medicine, 1986
- Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: Colestipol and clofibrateMetabolism, 1983
- HYPERCALCAEMIC OSTEOMALACIA DUE TO ALUMINIUM TOXICITYThe Lancet, 1982
- Seasonal Changes in Human Plasma Levels of 25-Hydroxyvitamin DNature, 1974
- SECONDARY HYPERPARATHYROIDISM AND RENAL OSTEO-DYSTROPHY IN CHRONIC RENAL FAILUREMedicine, 1969